These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 36707189)

  • 1. Predicting severe chronic obstructive pulmonary disease exacerbations using quantitative CT: a retrospective model development and external validation study.
    Chaudhary MFA; Hoffman EA; Guo J; Comellas AP; Newell JD; Nagpal P; Fortis S; Christensen GE; Gerard SE; Pan Y; Wang D; Abtin F; Barjaktarevic IZ; Barr RG; Bhatt SP; Bodduluri S; Cooper CB; Gravens-Mueller L; Han MK; Kazerooni EA; Martinez FJ; Menchaca MG; Ortega VE; Iii RP; Schroeder JD; Woodruff PG; Reinhardt JM
    Lancet Digit Health; 2023 Feb; 5(2):e83-e92. PubMed ID: 36707189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort.
    Han MK; Quibrera PM; Carretta EE; Barr RG; Bleecker ER; Bowler RP; Cooper CB; Comellas A; Couper DJ; Curtis JL; Criner G; Dransfield MT; Hansel NN; Hoffman EA; Kanner RE; Krishnan JA; Martinez CH; Pirozzi CB; O'Neal WK; Rennard S; Tashkin DP; Wedzicha JA; Woodruff P; Paine R; Martinez FJ;
    Lancet Respir Med; 2017 Aug; 5(8):619-626. PubMed ID: 28668356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort.
    Hastie AT; Martinez FJ; Curtis JL; Doerschuk CM; Hansel NN; Christenson S; Putcha N; Ortega VE; Li X; Barr RG; Carretta EE; Couper DJ; Cooper CB; Hoffman EA; Kanner RE; Kleerup E; O'Neal WK; Paine R; Peters SP; Alexis NE; Woodruff PG; Han MK; Meyers DA; Bleecker ER;
    Lancet Respir Med; 2017 Dec; 5(12):956-967. PubMed ID: 29146301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal Follow-Up of Participants With Tobacco Exposure and Preserved Spirometry.
    McKleroy W; Shing T; Anderson WH; Arjomandi M; Awan HA; Barjaktarevic I; Barr RG; Bleecker ER; Boscardin J; Bowler RP; Buhr RG; Criner GJ; Comellas AP; Curtis JL; Dransfield M; Doerschuk CM; Dolezal BA; Drummond MB; Han MK; Hansel NN; Helton K; Hoffman EA; Kaner RJ; Kanner RE; Krishnan JA; Lazarus SC; Martinez FJ; Ohar J; Ortega VE; Paine R; Peters SP; Reinhardt JM; Rennard S; Smith BM; Tashkin DP; Couper D; Cooper CB; Woodruff PG
    JAMA; 2023 Aug; 330(5):442-453. PubMed ID: 37526720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Respiratory Symptoms Items from the COPD Assessment Test Identify Ever-Smokers with Preserved Lung Function at Higher Risk for Poor Respiratory Outcomes. An Analysis of the Subpopulations and Intermediate Outcome Measures in COPD Study Cohort.
    Martinez CH; Murray S; Barr RG; Bleecker E; Bowler RP; Christenson SA; Comellas AP; Cooper CB; Couper D; Criner GJ; Curtis JL; Dransfield MT; Hansel NN; Hoffman EA; Kanner RE; Kleerup E; Krishnan JA; Lazarus SC; Leidy NK; O'Neal W; Martinez FJ; Paine R; Rennard SI; Tashkin DP; Woodruff PG; Han MK;
    Ann Am Thorac Soc; 2017 May; 14(5):636-642. PubMed ID: 28459622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting COPD exacerbations based on quantitative CT analysis: an external validation study.
    Wu J; Lu Y; Dong S; Wu L; Shen X
    Front Med (Lausanne); 2024; 11():1370917. PubMed ID: 38933101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Acute COPD Exacerbation Prediction Tool (ACCEPT): a modelling study.
    Adibi A; Sin DD; Safari A; Johnson KM; Aaron SD; FitzGerald JM; Sadatsafavi M
    Lancet Respir Med; 2020 Oct; 8(10):1013-1021. PubMed ID: 32178776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A clinical prediction model for hospitalized COPD exacerbations based on "treatable traits".
    Yii ACA; Loh CH; Tiew PY; Xu H; Taha AAM; Koh J; Tan J; Lapperre TS; Anzueto A; Tee AKH
    Int J Chron Obstruct Pulmon Dis; 2019; 14():719-728. PubMed ID: 30988606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Long-term Ambient Ozone Exposure With Respiratory Morbidity in Smokers.
    Paulin LM; Gassett AJ; Alexis NE; Kirwa K; Kanner RE; Peters S; Krishnan JA; Paine R; Dransfield M; Woodruff PG; Cooper CB; Barr RG; Comellas AP; Pirozzi CS; Han M; Hoffman EA; Martinez FJ; Woo H; Peng RD; Fawzy A; Putcha N; Breysse PN; Kaufman JD; Hansel NN;
    JAMA Intern Med; 2020 Jan; 180(1):106-115. PubMed ID: 31816012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Airway mucin MUC5AC and MUC5B concentrations and the initiation and progression of chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort.
    Radicioni G; Ceppe A; Ford AA; Alexis NE; Barr RG; Bleecker ER; Christenson SA; Cooper CB; Han MK; Hansel NN; Hastie AT; Hoffman EA; Kanner RE; Martinez FJ; Ozkan E; Paine R; Woodruff PG; O'Neal WK; Boucher RC; Kesimer M
    Lancet Respir Med; 2021 Nov; 9(11):1241-1254. PubMed ID: 34058148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers Predictive of Exacerbations in the SPIROMICS and COPDGene Cohorts.
    Keene JD; Jacobson S; Kechris K; Kinney GL; Foreman MG; Doerschuk CM; Make BJ; Curtis JL; Rennard SI; Barr RG; Bleecker ER; Kanner RE; Kleerup EC; Hansel NN; Woodruff PG; Han MK; Paine R; Martinez FJ; Bowler RP; O'Neal WK;
    Am J Respir Crit Care Med; 2017 Feb; 195(4):473-481. PubMed ID: 27579823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk Factors for Chronic Obstructive Pulmonary Disease Exacerbations among Individuals without a History of Recent Exacerbations: A COPDGene Analysis.
    Ferrera MC; Lopez CL; Murray S; Jain RG; Labaki WW; Make BJ; Han MK
    Ann Am Thorac Soc; 2024 Mar; 21(3):421-427. PubMed ID: 37796613
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease.
    Dransfield MT; Kunisaki KM; Strand MJ; Anzueto A; Bhatt SP; Bowler RP; Criner GJ; Curtis JL; Hanania NA; Nath H; Putcha N; Roark SE; Wan ES; Washko GR; Wells JM; Wendt CH; Make BJ;
    Am J Respir Crit Care Med; 2017 Feb; 195(3):324-330. PubMed ID: 27556408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary artery enlargement and cystic fibrosis pulmonary exacerbations: a cohort study.
    Wells JM; Farris RF; Gosdin TA; Dransfield MT; Wood ME; Bell SC; Rowe SM
    Lancet Respir Med; 2016 Aug; 4(8):636-645. PubMed ID: 27298019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NT-proBNP in stable COPD and future exacerbation risk: Analysis of the SPIROMICS cohort.
    Labaki WW; Xia M; Murray S; Curtis JL; Barr RG; Bhatt SP; Bleecker ER; Hansel NN; Cooper CB; Dransfield MT; Wells JM; Hoffman EA; Kanner RE; Paine R; Ortega VE; Peters SP; Krishnan JA; Bowler RP; Couper DJ; Woodruff PG; Martinez FJ; Martinez CH; Han MK
    Respir Med; 2018 Jul; 140():87-93. PubMed ID: 29957287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhaled corticosteroids with combination inhaled long-acting beta2-agonists and long-acting muscarinic antagonists for chronic obstructive pulmonary disease.
    van Geffen WH; Tan DJ; Walters JA; Walters EH
    Cochrane Database Syst Rev; 2023 Dec; 12(12):CD011600. PubMed ID: 38054551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occupational Exposures and Computed Tomographic Imaging Characteristics in the SPIROMICS Cohort.
    Paulin LM; Smith BM; Koch A; Han M; Hoffman EA; Martinez C; Ejike C; Blanc PD; Rous J; Barr RG; Peters SP; Paine R; Pirozzi C; Cooper CB; Dransfield MT; Comellas AP; Kanner RE; Drummond MB; Putcha N; Hansel NN
    Ann Am Thorac Soc; 2018 Dec; 15(12):1411-1419. PubMed ID: 30339479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for acute exacerbations of COPD in a primary care population: a retrospective observational cohort study.
    Müllerová H; Shukla A; Hawkins A; Quint J
    BMJ Open; 2014 Dec; 4(12):e006171. PubMed ID: 25524545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Nomogram for Predicting Severe Exacerbations in Stable COPD Patients.
    Chen X; Wang Q; Hu Y; Zhang L; Xiong W; Xu Y; Yu J; Wang Y
    Int J Chron Obstruct Pulmon Dis; 2020; 15():379-388. PubMed ID: 32110006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations: a RCT.
    Devereux G; Cotton S; Fielding S; McMeekin N; Barnes PJ; Briggs A; Burns G; Chaudhuri R; Chrystyn H; Davies L; Soyza A; Gompertz S; Haughney J; Innes K; Kaniewska J; Lee A; Morice A; Norrie J; Sullivan A; Wilson A; Price D
    Health Technol Assess; 2019 Jul; 23(37):1-146. PubMed ID: 31343402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.